• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[老年患者长期使用香豆素类制剂治疗]

[Long-term treatment with coumarin preparations in advanced age].

作者信息

Bán A

出版信息

Z Gesamte Inn Med. 1984 Dec 15;39(24):617-20.

PMID:6442071
Abstract

It is reported on the occurrence of haemorrhagic complications at old age in patients treated with coumarin. Altogether 352 patients were examined, 96 of them were older than 70 years. A small part of the patients, above all men with obliterating vascular occlusions of the lower extremity were additionally given also thrombocyte aggregation inhibitors. The effective prothrombin level was nearly the same in the two, groups, i.e. in the patients younger and older than 70 years. There was no difference in frequency and severity of the haemorrhages with the exception of macrohaematuria which, however, appeared above all in the younger age group and in women older than 70 years. Under observation of the indications and with a regular control a long-term treatment with coumarin preparations can performed without any particular risk also at old age.

摘要

据报道,使用香豆素治疗的老年患者出现了出血并发症。总共检查了352名患者,其中96名年龄超过70岁。一小部分患者,尤其是患有下肢闭塞性血管阻塞的男性,还额外服用了血小板聚集抑制剂。两组患者(即70岁以下和70岁以上的患者)的有效凝血酶原水平几乎相同。除肉眼血尿外,出血的频率和严重程度没有差异,然而,肉眼血尿主要出现在较年轻的年龄组和70岁以上的女性中。在严格遵循适应证并定期监测的情况下,香豆素制剂的长期治疗在老年患者中也可进行,且无任何特殊风险。

相似文献

1
[Long-term treatment with coumarin preparations in advanced age].[老年患者长期使用香豆素类制剂治疗]
Z Gesamte Inn Med. 1984 Dec 15;39(24):617-20.
2
[Coumarin necrosis].
Schweiz Med Wochenschr. 1969 Jul 26;99(30):1069-77.
3
[Long-term anticoagulant therapy in subjects over 75 years of age. 100 cases].
Arch Mal Coeur Vaiss. 1977 May;70(5):521-9.
4
Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
Thromb Haemost. 1994 Jan;71(1):7-11.
5
Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.低分子量肝素(依诺肝素)与口服抗凝治疗(醋硝香豆素)用于老年人深静脉血栓形成的长期治疗:一项随机试验
Thromb Haemost. 2000 Oct;84(4):559-64.
6
Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.三氟醋柳酸与口服抗凝剂用于生物人工瓣膜置换术后血栓栓塞一级预防的比较(TRAC):前瞻性、随机、合作试验
Eur J Cardiothorac Surg. 2005 May;27(5):854-60. doi: 10.1016/j.ejcts.2004.12.064.
7
[Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].[细胞色素P450 2C9基因型对接受醋硝香豆素治疗患者出血并发症的意义]
Orv Hetil. 2005 Apr 17;146(16):739-43.
8
Risks of oral anticoagulant therapy with increasing age.随着年龄增长口服抗凝治疗的风险。
Arch Intern Med. 2005 Jul 11;165(13):1527-32. doi: 10.1001/archinte.165.13.1527.
9
[Long-term application of warfarin or acenocumarol in patients with fibrillating arrhythmia: the effects compared].[华法林或醋硝香豆素在房颤患者中的长期应用:疗效比较]
Klin Med (Mosk). 2005;83(1):24-7.
10
[Hemorrhagic complications and thrombotic phenomena in oral anticoagulation of elderly patients].
Rev Clin Esp. 1997 May;197(5):323-8.

引用本文的文献

1
Anticoagulation-related intracranial extracerebral haemorrhage.抗凝相关的颅内脑外出血
J Neurol Neurosurg Psychiatry. 1989 Jul;52(7):829-37. doi: 10.1136/jnnp.52.7.829.